The import of insulin to Switzerland is forecasted to grow steadily over the next five years, starting from 2.0813 million USD in 2024 to 2.3957 million USD in 2028. In 2023, the actual value stood at 2.0095 million USD, indicating a consistent year-on-year increase. The percentage variations are approximately 3.88% from 2024 to 2025, 3.67% from 2025 to 2026, 3.47% from 2026 to 2027, and 3.29% from 2027 to 2028. The compound annual growth rate (CAGR) for the period 2024-2028 is forecasted to be around 3.57%.
Future trends to watch for include advancements in insulin delivery technologies and the potential impact of new market entrants. Additionally, fluctuations in international trade policies and the strengthening of local manufacturing capabilities could influence the import dynamics.
